Study of T3 for the Treatment of Fibromyalgia
Completed · Not applicable · Has a placebo group
Conditions studied: Fibromyalgia
In brief
Determine if T3 - the active form of thyroid hormone - is beneficial in fibromyalgia. Determine the feasibility and promise of an appropriately powered future prospective randomized controlled study of using T3 (the active form of thyroid hormone) for the treatment of fibromyalgia. We specifically aim to assess the feasibility, cost, obstacles and promise of conducting a prospective controlled study in the future.
Key facts
- Study ID
- NCT00903877
- Run by
- Stanford University
- People needed
- 51
- Starts
- 2009-05-01
- Expected to finish
- 2011-06-01
- Last updated by the study team
- 2017-07-14
Who can join
Age: 18 and older, up to 50. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Age 18-50
- Meet american college of rheumatology criteria for fibromyalgia
- at baseline report an average pain of 4 or more on a brief Pain Inventory.
- can climb 2 flights of stairs without shortness of breath.
You may not qualify if…
- new medication change in the last 2 months
- any cardiac disease at all
- known thyroid disease before or after thyroid screening bloodwork
- unstable medical or psychiatric disease.
- Known inflammatory or rheumatic disease other than fibromyalgia
- substance abuse in the last year
- suicidality or depression as indicated by a Beck Depression Inventory of 30 or above
- concomitant herbal medications
- multiple severe medication allergies
- the assessment of the research team that inclusion of the subject could in some way compromise the safety and validity of the study.
- diabetes
- smoking
- Known uncontrolled hypertension
- known uncontrolled hypercholesterolemia
Where it is running
- Stanford University School of Medicine — Stanford, California, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.